CCB
SAGE

Cutter & Co Brokerage’s Sage Therapeutics SAGE Stock Holding History

Cutter & Co Brokerage’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,944
Closed -$210K – 267
2021
Q4 		$210K Sell
4,944
-1,700
-26% -$71.2K 0.06% 243
2021
Q3 		$294K Sell
6,644
-799
-11% -$36.6K 0.07% 215
2021
Q2 		$423K Sell
7,443
-245
-3% -$17.3K 0.1% 175
2021
Q1 		$575K Sell
7,688
-2,429
-24% -$199K 0.14% 137
2020
Q4 		$875K Sell
10,117
-723
-7% -$53.3K 0.23% 94
2020
Q3 		$663K Buy
10,840
+593
+6% +$30.1K 0.2% 102
2020
Q2 		$426K Buy
10,247
+2,290
+29% +$83.1K 0.14% 130
2020
Q1 		$229K Buy
7,957
+668
+9% +$38.7K 0.09% 172
2019
Q4 		$526K Buy
7,289
+945
+15% +$116K 0.18% 112
2019
Q3 		$890K Hold
6,344
– – 0.29% 90
2019
Q2 		$1.16M Buy
6,344
+130
+2% +$22.2K 0.37% 72
2019
Q1 		$988K Buy
6,214
+455
+8% +$65.9K 0.28% 78
2018
Q4 		$552K Buy
5,759
+949
+20% +$109K 0.21% 111
2018
Q3 		$679K Sell
4,810
-500
-9% -$77.2K 0.23% 108
2018
Q2 		$831K Hold
5,310
– – 0.32% 87
2018
Q1 		$855K Buy
5,310
+120
+2% +$20.4K 0.34% 78
2017
Q4 		$855K Sell
5,190
-36
-0.7% -$3.49K 0.35% 71
2017
Q3 		$326K Sell
5,226
-70
-1% -$5.5K 0.13% 162
2017
Q2 		$422K Buy
5,296
+1,196
+29% +$86.5K 0.17% 136
2017
Q1 		$291K Buy
+4,100
New +$240K 0.12% 174

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Cutter & Co Brokerage's SAGE Position: Q1 2022 in Review

Cutter & Co Brokerage sold out of Sage Therapeutics (SAGE) in Q1 2022, closing a stake of 4,944 shares — an estimated $210K sold.

Cutter & Co Brokerage first reported a position in SAGE in Q1 2017 and held it in 20 quarters. The position peaked at $1.16M in Q2 2019. 212 funds tracked by Wall St. Rank hold SAGE as of Q1 2022.

  • Cutter & Co Brokerage reported no remaining Sage Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Cutter & Co Brokerage sold 4,944 Sage Therapeutics shares in Q1 2022, an estimated $210K.
  • Cutter & Co Brokerage first reported a position in Sage Therapeutics in Q1 2017 and held it in 20 quarters.
  • Cutter & Co Brokerage's Sage Therapeutics position peaked at $1.16M in Q2 2019.
  • 212 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2022.

Based on Cutter & Co Brokerage's 13F filing for Q1 2022, filed 3 May 2022.